Athletes and arrhythmias

Journal of Cardiovascular Electrophysiology

Volumn 21, Issue 10, 2010, Pages 1184-1189

  Link, Mark S ^a   Mark Estes, N A ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

athletic; atrial fibrillation; implantable cardioverter defibrillation; sudden death; ventricular tachycardia

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DRONEDARONE; FLECAINIDE; PROPAFENONE;

ATHLETE; ATRIOVENTRICULAR REENTRANT TACHYCARDIA; BRADYCARDIA; CATHETER ABLATION; COMMOTIO CORDIS; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART BLOCK; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NONHUMAN; NONSUSTAINED VENTRICULAR TACHYCARDIA; PACEMAKER; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; THROMBOEMBOLISM; VENTRICULAR PREMATURE CONTRACTION; VIROIDAL PLANT DISEASE; WOLFF PARKINSON WHITE SYNDROME;

ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; HUMANS; PREVALENCE; RISK ASSESSMENT; SPORTS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 78649432911     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2010.01808.x     Document Type: Review

References (42)

1. Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G,: Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003; 42: 1959-1963.
2. Maron BJ, Zipes DP,: Introduction: Eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations. J Am Coll Cardiol 2005; 45: 1318-1321.
3. Pelliccia A, Fagard R, Bjornstad HH, Anastassakis A, Arbustini E, Assanelli D, Biffi A, Borjesson M, Carre F, Corrado D, Delise P, Dorwarth U, Hirth A, Heidbuchel H, Hoffmann E, Mellwig KP, Panhuyzen-Goedkoop N, Pisani A, Solberg EE, Van-Buuren F, Vanhees L, Blomstrom-Lundqvist C, Deligiannis A, Dugmore D, Glikson M, Hoff PI, Hoffmann A, Horstkotte D, Nordrehaug JE, Oudhof J, McKenna WJ, Penco M, Priori S, Reybrouck T, Senden J, Spataro A, Thiene G,: Recommendations for competitive sports participation in athletes with cardiovascular disease: A consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005; 26: 1422-1445.
4. Mitchell JH, Haskell W, Snell P, Van Camp SP,: Task Force 8: Classification of sports. 36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes With Cardiovascular Abnormalities. J Am Coll Cardiol 2005; 45: 1364-1367.
5. Link MS, Olshansky B, Estes NA III,: Cardiac arrhythmias and the athlete. Curr Opin Cardiol 1999; 14: 24-29.
6. Furlanello F, Bertoldi A, Dallago M, Galassi A, Fernando F, Biffi A, Mazzone P, Pappone C, Chierchia S,: Atrial fibrillation in elite athletes. J Cardiovasc Electrophysiol 1998; 9: S63-S68.
7. Grimsmo J, Grundvold I, Maehlum S, Arnesen H,: High prevalence of atrial fibrillation in long-term endurance cross-country skiers: Echocardiographic findings and possible predictors-a 28-30 years follow-up study. Eur J Cardiovasc Prev Rehabil 17: 100-105.
8. Pelliccia A, Culasso F, Di Paolo FM, Maron BJ,: Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med 1999; 130: 23-31.
9. Bode F, Sachs F, Franz MR,: Tarantula peptide inhibits atrial fibrillation. Nature 2001; 409: 35-36.
10. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL,: ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-e354.
11. Furlanello F, Lupo P, Pittalis M, Foresti S, Vitali-Serdoz L, Francia P, De Ambroggi G, Ferrero P, Nardi S, Inama G, De Ambroggi L, Cappato R,: Radiofrequency catheter ablation of atrial fibrillation in athletes referred for disabling symptoms preventing usual training schedule and sport competition. J Cardiovasc Electrophysiol 2008; 19: 457-462.
12. Zipes DP, Ackerman MJ, Estes III NAM, Grant AO, Myerburg RJ, Van Hare G,: Task Force 7: Arrhythmias. 36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes With Cardiovascular Abnormalities. J Am Coll Cardiol 2005; 45: 43-52.
13. Wellens HJ, Rodriguez LM, Timmermans C, Smeets JL,: The asymptomatic patient with the Wolff-Parkinson-White electrocardiogram. Pacing Clin Electrophysiol 1997; 20: 2082-2086.
14. Pappone C, Santinelli V,: Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? Catheter ablation should be performed in asymptomatic patients with Wolff-Parkinson-White syndrome. Circulation 2005; 112: 2207-2215; discussion 2216.
15. Thompson PD, Franklin BA, Balady GJ, Blair SN, Corrado D, Estes NA, III, Fulton JE, Gordon NF, Haskell WL, Link MS, Maron BJ, Mittleman MA, Pelliccia A, Wenger NK, Willich SN, Costa F,: Exercise and acute cardiovascular events placing the risks into perspective: A scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation 2007; 115: 2358-2368.
16. Albert CM, Mittleman MA, Chae CU, Lee IM, Hennekens CH, Manson JE,: Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 2000; 343: 1355-1361.
17. Maron BJ,: Cardiovascular risks to young persons on the athletic field. Ann Int Med 1998; 129: 379-386.
18. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO,: Sudden deaths in young competitive athletes: Analysis of 1866 deaths in the United States, 1980-2006. Circulation 2009; 119: 1085-1092.
19. Maron BJ,: Sudden death in young athletes. N Engl J Med 2003; 349: 1064-1075.
20. Puranik R, Chow CK, Duflou JA, Kilborn MJ, McGuire MA,: Sudden death in the young. Heart Rhythm 2005; 2: 1277-1282.
21. Eckart RE, Scoville SL, Campbell CL, Shry EA, Stajduhar KC, Potter RN, Pearse LA, Virmani R,: Sudden death in young adults: A 25-year review of autopsies in military recruits. Ann Intern Med 2004; 141: 829-834.
22. Corrado D, Basso C, Schiavon M, Thiene G,: Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998; 339: 364-369.
23. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA, III, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P,: Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 2007; 298: 405-412. (Pubitemid 47124061)
24. Maron BJ,: Hypertrophic cardiomyopathy; A systemic review. JAMA 2002; 287: 1308-1320.
25. Maron BJ, Spirito P,: Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol 2008; 19: 1118-1126.
26. Maron BJ, Ackerman MJ, Nishimura RA, Pyeritz RE, Towbin JA, Udelson JE,: Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. 36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes With Cardiovascular Abnormalities. J Am Coll Cardiol 2005; 45: 1340-1345.
27. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB,: Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 2006; 113: 1807-1816.
28. Graham TP, Jr, Driscoll DJ, Gersony WM, Newburger JW, Rocchini A, Towbin JA,: Task Force 2: Congenital heart disease. J Am Coll Cardiol 2005; 45: 1326-1333.
29. Goldenberg I, Moss AJ,: Long QT syndrome. J Am Coll Cardiol 2008; 51: 2291-2300.
30. Tester DJ, Will ML, Haglund CM, Ackerman MJ,: Effect of clinical phenotype on yield of long QT syndrome genetic testing. J Am Coll Cardiol 2006; 47: 764-768.
31. Vyas H, Hejlik J, Ackerman MJ,: Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: Diagnostic accuracy of the paradoxical QT response. Circulation 2006; 113: 1385-1392.
32. Madias C, Maron BJ, Weinstock J, Estes NA, III, Link MS,: Commotio cordis-sudden cardiac death with chest wall impact. J Cardiovasc Electrophysiol 2007; 18: 115-122.
33. Maron BJ, Poliac LC, Kaplan JA, Mueller FO,: Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. N Engl J Med 1995; 333: 337-342.
34. Link MS, Wang PJ, Pandian NG, Bharati S, Udelson JE, Lee MY, Vecchiotti MA, VanderBrink BA, Mirra G, Maron BJ, Estes NA, III,: An experimental model of sudden death due to low-energy chest-wall impact (commotio cordis). N Engl J Med 1998; 338: 1805-1811.
35. Link MS, Maron BJ, VanderBrink BA, Takeuchi M, Pandian NG, Wang PJ, Estes NA, III,: Impact directly over the cardiac silhouette is necessary to produce ventricular fibrillation in an experimental model of commotio cordis. J Am Coll Cardiol 2001; 37: 649-654.
36. Link MS, Maron BJ, Wang PJ, Pandian NG, VanderBrink BA, Estes NA, III,: Reduced risk of sudden death from chest wall blows (commotio cordis) with safety baseballs. Pediatrics 2002; 109: 873-877.
37. Link MS, Maron BJ, Wang PJ, VanderBrink BA, Zhu W, Estes NA, III,: Upper and lower limits of vulnerability to sudden arrhythmic death with chest-wall impact (commotio cordis). J Am Coll Cardiol 2003; 41: 99-104.
38. Weinstock J, Maron BJ, Song C, Mane PP, Estes NA, III, Link MS,: Failure of commercially available chest wall protectors to prevent sudden cardiac death induced by chest wall blows in an experimental model of commotio cordis. Pediatrics 2006; 117: e656-e662.
39. Link MS,: Mechanically induced sudden death in chest wall impact. Prog Biophys Molecular Biol 2003; 82: 175-186.
40. Bode F, Franz MR, Wilke I, Bonnemeier H, Schunkert H, Wiegand UK,: Ventricular fibrillation induced by stretch pulse: Implications for sudden death due to commotio cordis. J Cardiovasc Electrophysiol 2006; 17: 1011-1017.
41. Madias C, Maron BJ, Supron S, Estes NA, III, Link MS,: Cell membrane stretch and chest blow-induced ventricular fibrillation: Commotio cordis. J Cardiovasc Electrophysiol 2008; 19: 1304-1309.
42. Link MS, Wang PJ, VanderBrink BA, Avelar E, Pandian NG, Maron BJ, Estes NA, III,: Selective activation of the K(+)(ATP) channel is a mechanism by which sudden death is produced by low-energy chest-wall impact (Commotio cordis). Circulation 1999; 100: 413-418.